mrna assay Search Results


nebnext poly a mrna magnetic isolation module  (New England Biolabs)
99
New England Biolabs nebnext poly a mrna magnetic isolation module
Nebnext Poly A Mrna Magnetic Isolation Module, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nebnext poly a mrna magnetic isolation module/product/New England Biolabs
Average 99 stars, based on 1 article reviews
nebnext poly a mrna magnetic isolation module - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier
magnospheretm ultrapure mrna purification kit  (TaKaRa)
94
TaKaRa magnospheretm ultrapure mrna purification kit
Magnospheretm Ultrapure Mrna Purification Kit, supplied by TaKaRa, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/magnospheretm ultrapure mrna purification kit/product/TaKaRa
Average 94 stars, based on 1 article reviews
magnospheretm ultrapure mrna purification kit - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier
2 o methyltransferase  (New England Biolabs)
96
New England Biolabs 2 o methyltransferase
2 O Methyltransferase, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/2 o methyltransferase/product/New England Biolabs
Average 96 stars, based on 1 article reviews
2 o methyltransferase - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier
smart seq mrna kit  (TaKaRa)
99
TaKaRa smart seq mrna kit
Smart Seq Mrna Kit, supplied by TaKaRa, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/smart seq mrna kit/product/TaKaRa
Average 99 stars, based on 1 article reviews
smart seq mrna kit - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier
igf2bp1  (Proteintech)
97
Proteintech igf2bp1
Igf2bp1, supplied by Proteintech, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/igf2bp1/product/Proteintech
Average 97 stars, based on 1 article reviews
igf2bp1 - by Bioz Stars, 2026-05
97/100 stars
  Buy from Supplier
cpsf7  (Novus Biologicals)
90
Novus Biologicals cpsf7
Novel complexes copurifying with ICP4 (spectral counts).
Cpsf7, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cpsf7/product/Novus Biologicals
Average 90 stars, based on 1 article reviews
cpsf7 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
turbocapture 96 mrna kit  (Qiagen)
95
Qiagen turbocapture 96 mrna kit
Novel complexes copurifying with ICP4 (spectral counts).
Turbocapture 96 Mrna Kit, supplied by Qiagen, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/turbocapture 96 mrna kit/product/Qiagen
Average 95 stars, based on 1 article reviews
turbocapture 96 mrna kit - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier
truseq stranded mrna sample prep kit  (Illumina Inc)
99
Illumina Inc truseq stranded mrna sample prep kit
ACSL3 loss confers resistance to palmitic acid–induced cell death. (A) Left, ACSL3 protein by western blot; right, viability of ACSL3-KO and NC HLF cells after 72 hours PA. (B) Left, INSIG1 protein by western blot; right, viability of INSIG1-KO and NC HLF cells after 72 hours PA. (C, D) Primary human hepatocytes (isolated from humanized mice) transfected with ACSL3 siRNA; ACSL3 <t>mRNA</t> by RT-qPCR normalized to ACTB (C), and PA-induced changes in viability and caspase-3/7 activity (D). (E) Real-time imaging (IncuCyte) of confluence in ACSL3-KO and NC HLF cells during day 1–6 PA exposure. (F) Viability of HLF cells treated with PA with or without the pan-ACSL inhibitor triacsin. (G) Flow-cytometric quantification of Annexin V and propidium iodide-positive cells after 24 hours PA in ACSL3-KO versus NC HLF cells. (H) ACSL3 and GRP78 mRNA by RT-qPCR normalized to ACTB following PA exposure. Abbreviations: ACSL3, acyl-CoA synthetase long-chain family member 3; KO, knockout; NC, negative control; PA, palmitic acid; siRNA, small interfering RNA; WT, wild type.
Truseq Stranded Mrna Sample Prep Kit, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/truseq stranded mrna sample prep kit/product/Illumina Inc
Average 99 stars, based on 1 article reviews
truseq stranded mrna sample prep kit - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier
tianseq mrna  (tiangen biotech co)
93
tiangen biotech co tianseq mrna
ACSL3 loss confers resistance to palmitic acid–induced cell death. (A) Left, ACSL3 protein by western blot; right, viability of ACSL3-KO and NC HLF cells after 72 hours PA. (B) Left, INSIG1 protein by western blot; right, viability of INSIG1-KO and NC HLF cells after 72 hours PA. (C, D) Primary human hepatocytes (isolated from humanized mice) transfected with ACSL3 siRNA; ACSL3 <t>mRNA</t> by RT-qPCR normalized to ACTB (C), and PA-induced changes in viability and caspase-3/7 activity (D). (E) Real-time imaging (IncuCyte) of confluence in ACSL3-KO and NC HLF cells during day 1–6 PA exposure. (F) Viability of HLF cells treated with PA with or without the pan-ACSL inhibitor triacsin. (G) Flow-cytometric quantification of Annexin V and propidium iodide-positive cells after 24 hours PA in ACSL3-KO versus NC HLF cells. (H) ACSL3 and GRP78 mRNA by RT-qPCR normalized to ACTB following PA exposure. Abbreviations: ACSL3, acyl-CoA synthetase long-chain family member 3; KO, knockout; NC, negative control; PA, palmitic acid; siRNA, small interfering RNA; WT, wild type.
Tianseq Mrna, supplied by tiangen biotech co, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tianseq mrna/product/tiangen biotech co
Average 93 stars, based on 1 article reviews
tianseq mrna - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
anti igf2 bp3 rabbit pab  (Proteintech)
96
Proteintech anti igf2 bp3 rabbit pab
ACSL3 loss confers resistance to palmitic acid–induced cell death. (A) Left, ACSL3 protein by western blot; right, viability of ACSL3-KO and NC HLF cells after 72 hours PA. (B) Left, INSIG1 protein by western blot; right, viability of INSIG1-KO and NC HLF cells after 72 hours PA. (C, D) Primary human hepatocytes (isolated from humanized mice) transfected with ACSL3 siRNA; ACSL3 <t>mRNA</t> by RT-qPCR normalized to ACTB (C), and PA-induced changes in viability and caspase-3/7 activity (D). (E) Real-time imaging (IncuCyte) of confluence in ACSL3-KO and NC HLF cells during day 1–6 PA exposure. (F) Viability of HLF cells treated with PA with or without the pan-ACSL inhibitor triacsin. (G) Flow-cytometric quantification of Annexin V and propidium iodide-positive cells after 24 hours PA in ACSL3-KO versus NC HLF cells. (H) ACSL3 and GRP78 mRNA by RT-qPCR normalized to ACTB following PA exposure. Abbreviations: ACSL3, acyl-CoA synthetase long-chain family member 3; KO, knockout; NC, negative control; PA, palmitic acid; siRNA, small interfering RNA; WT, wild type.
Anti Igf2 Bp3 Rabbit Pab, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti igf2 bp3 rabbit pab/product/Proteintech
Average 96 stars, based on 1 article reviews
anti igf2 bp3 rabbit pab - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier
turbocapture 384 mrna kit  (Qiagen)
94
Qiagen turbocapture 384 mrna kit
ACSL3 loss confers resistance to palmitic acid–induced cell death. (A) Left, ACSL3 protein by western blot; right, viability of ACSL3-KO and NC HLF cells after 72 hours PA. (B) Left, INSIG1 protein by western blot; right, viability of INSIG1-KO and NC HLF cells after 72 hours PA. (C, D) Primary human hepatocytes (isolated from humanized mice) transfected with ACSL3 siRNA; ACSL3 <t>mRNA</t> by RT-qPCR normalized to ACTB (C), and PA-induced changes in viability and caspase-3/7 activity (D). (E) Real-time imaging (IncuCyte) of confluence in ACSL3-KO and NC HLF cells during day 1–6 PA exposure. (F) Viability of HLF cells treated with PA with or without the pan-ACSL inhibitor triacsin. (G) Flow-cytometric quantification of Annexin V and propidium iodide-positive cells after 24 hours PA in ACSL3-KO versus NC HLF cells. (H) ACSL3 and GRP78 mRNA by RT-qPCR normalized to ACTB following PA exposure. Abbreviations: ACSL3, acyl-CoA synthetase long-chain family member 3; KO, knockout; NC, negative control; PA, palmitic acid; siRNA, small interfering RNA; WT, wild type.
Turbocapture 384 Mrna Kit, supplied by Qiagen, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/turbocapture 384 mrna kit/product/Qiagen
Average 94 stars, based on 1 article reviews
turbocapture 384 mrna kit - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier
oligo dt 25 beads  (New England Biolabs)
96
New England Biolabs oligo dt 25 beads
ACSL3 loss confers resistance to palmitic acid–induced cell death. (A) Left, ACSL3 protein by western blot; right, viability of ACSL3-KO and NC HLF cells after 72 hours PA. (B) Left, INSIG1 protein by western blot; right, viability of INSIG1-KO and NC HLF cells after 72 hours PA. (C, D) Primary human hepatocytes (isolated from humanized mice) transfected with ACSL3 siRNA; ACSL3 <t>mRNA</t> by RT-qPCR normalized to ACTB (C), and PA-induced changes in viability and caspase-3/7 activity (D). (E) Real-time imaging (IncuCyte) of confluence in ACSL3-KO and NC HLF cells during day 1–6 PA exposure. (F) Viability of HLF cells treated with PA with or without the pan-ACSL inhibitor triacsin. (G) Flow-cytometric quantification of Annexin V and propidium iodide-positive cells after 24 hours PA in ACSL3-KO versus NC HLF cells. (H) ACSL3 and GRP78 mRNA by RT-qPCR normalized to ACTB following PA exposure. Abbreviations: ACSL3, acyl-CoA synthetase long-chain family member 3; KO, knockout; NC, negative control; PA, palmitic acid; siRNA, small interfering RNA; WT, wild type.
Oligo Dt 25 Beads, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/oligo dt 25 beads/product/New England Biolabs
Average 96 stars, based on 1 article reviews
oligo dt 25 beads - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

Image Search Results


Novel complexes copurifying with ICP4 (spectral counts).

Journal: PLoS ONE

Article Title: Temporal Association of Herpes Simplex Virus ICP4 with Cellular Complexes Functioning at Multiple Steps in PolII Transcription

doi: 10.1371/journal.pone.0078242

Figure Lengend Snippet: Novel complexes copurifying with ICP4 (spectral counts).

Article Snippet: The antibodies used to probe the membranes were; N15, polyclonal rabbit serum, for ICP4 (1:500), Trap220/Med 1 (sc-8998-X), Med6 (sc-9434), Med 4 (NBP1-84977; Novus Biologicals), Med23 (550429; BD Bio), CDK8 (sc-1521), Med12 (NB100-2357; Novus Biologicals), Med 13 ((NB100-60642; Novus Biologicals), Med 26 (sc-166614), TAF1 (sc735), TBP (233-R Covance), p62 (sc292-X), p80/XPB (sc-20696-x), CPSF2 (sc-165983), CPSF7 (NB100-61600; Novus Biologicals), Brahma (sc-6450), CHD3 (ABE86; Milipore), RUVBL1 (06-1299; Milipore), RUVBL2 (06-1300; Milipore) at the manufacturers recommended dilutions.

Techniques:

Western blot analysis of nuclear extracts (NE) or affinity purified (PD) samples collected at 6 hpi using either wtICP4 (KOS) or TAP-wtICP4 (TAP) expressing viruses. Antibodies directed against (A) p80 and p62 of TFIIH, (B) CPSF2 and CPSF7 of the cleavage and polyadenylation complex and (C) Brahma of Swi/Snf, CHD3 of the Nurd complex, and RuvBL1 and RuvBL2 of the Ino80 complex were used.

Journal: PLoS ONE

Article Title: Temporal Association of Herpes Simplex Virus ICP4 with Cellular Complexes Functioning at Multiple Steps in PolII Transcription

doi: 10.1371/journal.pone.0078242

Figure Lengend Snippet: Western blot analysis of nuclear extracts (NE) or affinity purified (PD) samples collected at 6 hpi using either wtICP4 (KOS) or TAP-wtICP4 (TAP) expressing viruses. Antibodies directed against (A) p80 and p62 of TFIIH, (B) CPSF2 and CPSF7 of the cleavage and polyadenylation complex and (C) Brahma of Swi/Snf, CHD3 of the Nurd complex, and RuvBL1 and RuvBL2 of the Ino80 complex were used.

Article Snippet: The antibodies used to probe the membranes were; N15, polyclonal rabbit serum, for ICP4 (1:500), Trap220/Med 1 (sc-8998-X), Med6 (sc-9434), Med 4 (NBP1-84977; Novus Biologicals), Med23 (550429; BD Bio), CDK8 (sc-1521), Med12 (NB100-2357; Novus Biologicals), Med 13 ((NB100-60642; Novus Biologicals), Med 26 (sc-166614), TAF1 (sc735), TBP (233-R Covance), p62 (sc292-X), p80/XPB (sc-20696-x), CPSF2 (sc-165983), CPSF7 (NB100-61600; Novus Biologicals), Brahma (sc-6450), CHD3 (ABE86; Milipore), RUVBL1 (06-1299; Milipore), RUVBL2 (06-1300; Milipore) at the manufacturers recommended dilutions.

Techniques: Western Blot, Affinity Purification, Expressing

ACSL3 loss confers resistance to palmitic acid–induced cell death. (A) Left, ACSL3 protein by western blot; right, viability of ACSL3-KO and NC HLF cells after 72 hours PA. (B) Left, INSIG1 protein by western blot; right, viability of INSIG1-KO and NC HLF cells after 72 hours PA. (C, D) Primary human hepatocytes (isolated from humanized mice) transfected with ACSL3 siRNA; ACSL3 mRNA by RT-qPCR normalized to ACTB (C), and PA-induced changes in viability and caspase-3/7 activity (D). (E) Real-time imaging (IncuCyte) of confluence in ACSL3-KO and NC HLF cells during day 1–6 PA exposure. (F) Viability of HLF cells treated with PA with or without the pan-ACSL inhibitor triacsin. (G) Flow-cytometric quantification of Annexin V and propidium iodide-positive cells after 24 hours PA in ACSL3-KO versus NC HLF cells. (H) ACSL3 and GRP78 mRNA by RT-qPCR normalized to ACTB following PA exposure. Abbreviations: ACSL3, acyl-CoA synthetase long-chain family member 3; KO, knockout; NC, negative control; PA, palmitic acid; siRNA, small interfering RNA; WT, wild type.

Journal: Hepatology Communications

Article Title: Genome-wide CRISPR screen identifies ACSL3 as a regulator of lipotoxicity and progression of MASLD

doi: 10.1097/HC9.0000000000000884

Figure Lengend Snippet: ACSL3 loss confers resistance to palmitic acid–induced cell death. (A) Left, ACSL3 protein by western blot; right, viability of ACSL3-KO and NC HLF cells after 72 hours PA. (B) Left, INSIG1 protein by western blot; right, viability of INSIG1-KO and NC HLF cells after 72 hours PA. (C, D) Primary human hepatocytes (isolated from humanized mice) transfected with ACSL3 siRNA; ACSL3 mRNA by RT-qPCR normalized to ACTB (C), and PA-induced changes in viability and caspase-3/7 activity (D). (E) Real-time imaging (IncuCyte) of confluence in ACSL3-KO and NC HLF cells during day 1–6 PA exposure. (F) Viability of HLF cells treated with PA with or without the pan-ACSL inhibitor triacsin. (G) Flow-cytometric quantification of Annexin V and propidium iodide-positive cells after 24 hours PA in ACSL3-KO versus NC HLF cells. (H) ACSL3 and GRP78 mRNA by RT-qPCR normalized to ACTB following PA exposure. Abbreviations: ACSL3, acyl-CoA synthetase long-chain family member 3; KO, knockout; NC, negative control; PA, palmitic acid; siRNA, small interfering RNA; WT, wild type.

Article Snippet: Library preparation was performed in the Genomics Core (Institute of Microbiology) using the TruSeq Stranded mRNA Sample Prep Kit (Illumina) on an Apollo Library Prep System (Takara).

Techniques: Western Blot, Isolation, Transfection, Quantitative RT-PCR, Activity Assay, Imaging, Knock-Out, Negative Control, Small Interfering RNA

ACSL3 deficiency abrogates PA-induced activation of lipogenic programs without enhancing β-oxidation. (A–C) mRNA levels by RT-qPCR normalized to ACTB: CPT1, CPT2, and ACOX (A); SCD, ChREBP, and SREBP1 (B); PPARG and LXRA (C). Abbreviations: KO, knockout; WT, wild type.

Journal: Hepatology Communications

Article Title: Genome-wide CRISPR screen identifies ACSL3 as a regulator of lipotoxicity and progression of MASLD

doi: 10.1097/HC9.0000000000000884

Figure Lengend Snippet: ACSL3 deficiency abrogates PA-induced activation of lipogenic programs without enhancing β-oxidation. (A–C) mRNA levels by RT-qPCR normalized to ACTB: CPT1, CPT2, and ACOX (A); SCD, ChREBP, and SREBP1 (B); PPARG and LXRA (C). Abbreviations: KO, knockout; WT, wild type.

Article Snippet: Library preparation was performed in the Genomics Core (Institute of Microbiology) using the TruSeq Stranded mRNA Sample Prep Kit (Illumina) on an Apollo Library Prep System (Takara).

Techniques: Activation Assay, Quantitative RT-PCR, Knock-Out